Results 21 to 30 of about 694,618 (154)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne

Pleura and Peritoneum, 2022
Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis.
Casella Francesco, Bencivenga Maria, Rosati Riccardo, Fumagalli Uberto Romario, Marrelli Daniele, Pacelli Fabio, Macrì Antonio, Donini Annibale, Torroni Lorena, Pavarana Michele, De Manzoni Giovanni   +10 more
doaj   +1 more source

Intraperitoneal Chemotherapy Strategies in Pancreatic Ductal Adenocarcinoma: A Systematic Review of Hyperthermic Intraperitoneal Chemotherapy, Normothermic Intraperitoneal Chemotherapy, and Pressurized Intraperitoneal Aerosol Chemotherapy. [PDF]

Cancers (Basel)
Background: Peritoneal metastasis represents an aggressive disease pattern in pancreatic ductal adenocarcinoma (PDAC), traditionally associated with poor survival and limited therapeutic options.
Ganatra N, Abdelhakeem A, Jain P, Kamatham S, Elantably D, Adeoye O, Babiker HM, O'Donnell CD, Majeed U.   +8 more
europepmc   +2 more sources

Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC

Pleura and Peritoneum, 2022
Two surgical techniques used for peritoneal metastasis involve a risk of exposure to antineoplastic drugs (ADs): hyperthermic intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Benoist Hubert, Eveno Clarisse, Wilson Sarah, Vigneron Nicolas, Guilloit Jean-Marc, Morello Rémy, Simon Nicolas, Odou Pascal, Saint-Lorant Guillaume   +8 more
doaj   +1 more source

Pressurized intraperitoneal aerosol chemotherapy in nonresectable carcinomatosis from colorectal cancer [PDF]

Romanian Journal of Medical Practice, 2021
Peritoneal carcinomatosis colorectal cancer unfortunately represents a frequently encountered condition during the natural history of this malignancy which has been considered for a long period of time as a terminal event.
Nicolae BACALBASA, Irina BALESCU, Adnan Al ALOUL   +2 more
doaj   +1 more source

Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report

Pleura and Peritoneum, 2021
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new drug delivery method for intraabdominal cavity chemotherapy. It combines the benefits of a minimally invasive approach (low morbidity and easy to repeat) with the pharmacokinetic ...
Thibaudeau Emilie, Brianchon Corinne, Raoul Jean-Luc, Dumont Frédéric   +3 more
doaj   +1 more source

Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer [PDF]

, 2016
\(\bf Background:\) Intraperitoneal chemotherapy is used to treat peritoneal cancer. The pattern of gene expression changes of peritoneal cancer during intraperitoneal chemotherapy has not been studied before.
Reymond, Marc A., Rezniczek, Günther (Dr. rer. nat.), Jütte, Hendrik Jan, Hefler, Lukas A., Jüngst, Friederike, Tempfer, Clemens (Prof. Dr. med.), Hilal, Ziad (PD Dr. med.), Tannapfel, Andrea (Prof. Dr. med.)   +7 more
core   +3 more sources

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Gastric Cancer: Feasibility, Efficacy and Safety—A Systematic Review and Meta-Analysis [PDF]

Journal of Clinical Medicine
Hugo Santos-Sousa, Tiago Bouça-Machado, Jorge Nogueiro   +2 more
exaly   +2 more sources

Intra-operative characteristics of pressurized intraperitoneal aerosol chemotherapy.

, 2023
Intra-operative characteristics of pressurized intraperitoneal aerosol chemotherapy.
Pierre-Louis Conan (17511346), Adeline Aime (17511349), Hugo Picchi (17511355), Solène Doat (15006081), Marc Pocard (3795094), Jade Fawaz (17511352), Brice Malgras (17511343), Anne-Cécile Ezanno (17511340)   +7 more
core   +1 more source

Demographic characteristics of patients eligible for pressurized intraperitoneal aerosol chemotherapy for peritoneal metastases.

, 2023
Demographic characteristics of patients eligible for pressurized intraperitoneal aerosol chemotherapy for peritoneal metastases.
Pierre-Louis Conan (17511346), Adeline Aime (17511349), Hugo Picchi (17511355), Solène Doat (15006081), Marc Pocard (3795094), Jade Fawaz (17511352), Brice Malgras (17511343), Anne-Cécile Ezanno (17511340)   +7 more
core   +1 more source

Supplementary Figure 2 from PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases

, 2021
Mean concentration-time profiles of pressurized intraperitoneal aerosol chemotherapy (PIPAC) oxaliplatin (n = 14) in plasmatot (A) and ultrafiltrate (B)
Maria V. Babak (2425975), Jingshan Ho (3204198), Bettina Lieske (15040031), Wei Peng Yong (15027648), Raghav Sundar (14947057), Lingzhi Wang (15024093), Hon Lyn Tan (15027675), Wee Han Ang (1505530), Cheng Ean Chee (15025560), Jimmy B.Y. So (15040034), Guowei Kim (15040028), Asim Shabbir (6723638), Boon Cher Goh (10534721)   +12 more
core   +1 more source